ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

IOM Selects Advisors To Defense Department

February 5, 1993

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003